搜索





搜索





市场行情
/
股票
/
clgn
/

Collplant Biotechnologies Ltd

CLGN

添加自选

0.299USD

-0.001-0.30%

收盘 07-31 16:00（美东）报价延迟15分钟

3.82M总市值

亏损市盈率 TTM

Collplant Biotechnologies Ltd

0.299

-0.001-0.30%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

CLGN 利润表

您可以在这里找到Collplant Biotechnologies Ltd的年度或季度收入报告，以深入了解Collplant Biotechnologies Ltd的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

营业总收入

-96.45%73.00K

-63.41%60.00K

1825.00%77.00K

-28.11%179.00K

1996.94%2.06M

-45.15%164.00K

-90.70%4.00K

-97.55%249.00K

-77.37%98.00K

415.52%299.00K

-60.55%43.00K

15330.30%10.18M

556.06%433.00K

-81.29%58.00K

-22.14%109.00K

-90.45%66.00K

-99.54%66.00K

-44.34%310.00K

-96.62%140.00K

-16.04%691.00K

2280.95%14.50M

26.88%557.00K

510.90%4.15M

35.81%823.00K

2.53%609.00K

--439.00K

--679.00K

--606.00K

--594.00K

营业收入

-96.45%73.00K

-63.41%60.00K

1825.00%77.00K

-28.11%179.00K

1996.94%2.06M

-45.15%164.00K

-90.70%4.00K

-97.55%249.00K

-77.37%98.00K

415.52%299.00K

-60.55%43.00K

15330.30%10.18M

556.06%433.00K

-81.29%58.00K

-22.14%109.00K

-90.45%66.00K

-99.54%66.00K

-44.34%310.00K

-96.62%140.00K

-16.04%691.00K

2280.95%14.50M

26.88%557.00K

510.90%4.15M

35.81%823.00K

2.53%609.00K

--439.00K

--679.00K

--606.00K

--594.00K

主营业务成本

68.09%316.00K

-29.41%192.00K

-1.10%269.00K

-65.30%186.00K

-65.50%188.00K

-64.81%272.00K

-2.16%272.00K

-12.85%536.00K

67.69%545.00K

1146.77%773.00K

5.30%278.00K

1330.23%615.00K

948.39%325.00K

-88.69%62.00K

85.92%264.00K

-89.98%43.00K

-96.50%31.00K

62.13%548.00K

-90.15%142.00K

-42.65%429.00K

86.53%886.00K

-3.70%338.00K

123.41%1.44M

61.56%748.00K

13.10%475.00K

--351.00K

--645.00K

--463.00K

--420.00K

营业费用

-13.91%3.19M

-22.43%3.21M

-21.16%3.58M

-27.88%3.36M

-16.35%3.70M

-22.90%4.14M

-2.13%4.55M

3.28%4.66M

12.02%4.43M

13.37%5.37M

1.49%4.64M

6.02%4.51M

3.08%3.95M

15.07%4.73M

41.53%4.58M

13.24%4.25M

-14.30%3.83M

25.81%4.11M

-5.27%3.23M

37.21%3.75M

93.18%4.47M

7.74%3.27M

40.73%3.41M

15.59%2.74M

9.19%2.32M

--3.04M

--2.43M

--2.37M

--2.12M

研发费用

-20.29%1.68M

-22.14%1.98M

-27.19%2.09M

-25.36%2.01M

-12.51%2.10M

-18.31%2.54M

6.46%2.87M

4.78%2.70M

14.46%2.41M

18.05%3.11M

-2.95%2.69M

-0.96%2.57M

-6.24%2.10M

20.47%2.64M

45.55%2.78M

36.72%2.60M

37.29%2.24M

64.34%2.19M

107.17%1.91M

89.72%1.90M

101.60%1.63M

-10.00%1.33M

-14.56%921.00K

-7.56%1.00M

4.92%810.00K

--1.48M

--1.08M

--772.00K

折旧摊销及损耗

-13.93%210.00K

-10.74%216.00K

-12.55%223.00K

-12.26%229.00K

-12.86%244.00K

-14.79%242.00K

-6.25%255.00K

-1.88%261.00K

0.00%280.00K

-3.40%284.00K

-3.20%272.00K

1.92%266.00K

16.67%280.00K

31.25%294.00K

42.64%281.00K

45.81%261.00K

38.73%240.00K

34.94%224.00K

17.96%197.00K

9.82%179.00K

5.49%173.00K

-1.78%166.00K

-37.22%167.00K

24.43%163.00K

69.07%164.00K

--169.00K

--266.00K

--131.00K

--97.00K

营业利润

-89.02%-3.12M

20.73%-3.15M

22.79%-3.51M

27.87%-3.18M

61.93%-1.65M

21.59%-3.97M

1.30%-4.54M

-177.61%-4.41M

-23.02%-4.33M

-8.38%-5.07M

-3.00%-4.60M

235.65%5.68M

6.61%-3.52M

-22.92%-4.68M

-44.41%-4.47M

-36.63%-4.18M

-137.58%-3.77M

-40.21%-3.80M

-521.53%-3.09M

-60.12%-3.06M

687.35%10.03M

-4.51%-2.71M

142.01%734.00K

-8.63%-1.91M

-11.79%-1.71M

---2.60M

---1.75M

---1.76M

---1.53M

净非营业利息收入（费用）

利息收入

-90.82%18.00K

----

-88.89%24.00K

----

46.27%196.00K

-85.54%96.00K

-4.00%216.00K

130.59%196.00K

--134.00K

70.26%664.00K

152.81%225.00K

--85.00K

----

596.43%390.00K

32.84%89.00K

----

143.48%56.00K

--67.00K

700.00%72.00K

194.12%50.00K

--23.00K

----

-98.57%9.00K

--17.00K

----

--630.00K

----

利息费用

----

--57.00K

----

--169.00K

----

113.04%196.00K

----

1150.00%100.00K

384.21%92.00K

----

-27.27%8.00K

300.00%8.00K

375.00%19.00K

-98.67%26.00K

-99.21%11.00K

-66.67%2.00K

--4.00K

--1.95M

--1.39M

--6.00K

----

出售证券收益

----

-147.83%-285.00K

----

-379.17%-115.00K

----

87.30%-24.00K

-110.00%-42.00K

40.00%-39.00K

-27.96%67.00K

-470.59%-189.00K

48.72%-20.00K

41.44%-65.00K

113.04%93.00K

--51.00K

---39.00K

---111.00K

---713.00K

税前利润

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

---3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

----

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

除税后利润

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

---3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

----

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

持续经营利润

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

归属于母公司的净利润

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

归属于普通股东的净利润

-113.29%-3.10M

17.30%-3.21M

19.49%-3.48M

20.50%-3.35M

65.39%-1.45M

17.30%-3.88M

1.17%-4.33M

-173.06%-4.21M

-12.92%-4.20M

-6.54%-4.69M

0.05%-4.38M

234.47%5.76M

3.76%-3.71M

-16.68%-4.40M

-42.31%-4.38M

-41.05%-4.29M

-138.13%-3.86M

-29.85%-3.77M

-537.70%-3.08M

-54.13%-3.04M

732.35%10.12M

35.43%-2.91M

122.13%703.00K

-57.93%-1.97M

28.53%-1.60M

---4.50M

---3.18M

---1.25M

---2.24M

基本每股收益

-77.72%-0.23

25.92%-0.25

27.51%-0.27

23.09%-0.28

65.39%-0.13

17.30%-0.34

1.26%-0.38

-172.52%-0.37

-11.12%-0.37

-3.94%-0.41

3.16%-0.38

231.13%0.51

8.44%-0.33

-12.02%-0.39

-34.81%-0.39

-29.78%-0.39

-129.92%-0.36

15.70%-0.35

-390.20%-0.29

-5.13%-0.30

600.53%1.20

44.73%-0.42

114.81%0.10

-5.81%-0.28

49.98%-0.24

---0.75

---0.68

---0.27

---0.48

稀释每股收益

-77.72%-0.23

25.92%-0.25

27.51%-0.27

23.09%-0.28

65.39%-0.13

17.30%-0.34

1.26%-0.38

-175.12%-0.37

-11.12%-0.37

-3.94%-0.41

3.16%-0.38

226.58%0.49

8.44%-0.33

-12.02%-0.39

-34.81%-0.39

-29.78%-0.39

-129.92%-0.36

15.70%-0.35

-390.20%-0.29

-5.13%-0.30

600.53%1.20

44.73%-0.42

114.81%0.10

-5.81%-0.28

49.98%-0.24

---0.75

---0.68

---0.27

---0.48

每股派息

--0.00

----

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Collplant Biotechnologies Ltd 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 CLGN 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Collplant Biotechnologies Ltd 财年末的营收是多少？



Collplant Biotechnologies Ltd 2025 财年营收为 2.37M，高于上一财年的515.00K。

Collplant Biotechnologies Ltd 最近一个季度的营收是多少？



Collplant Biotechnologies Ltd 最近一个季度的营收为 73.00K，同比增长 -96.45%。

Collplant Biotechnologies Ltd 全年的净利润是多少？



Collplant Biotechnologies Ltd 2025 财年净利润为 -11.49M。

Collplant Biotechnologies Ltd 上一季度的净利润是多少？



Collplant Biotechnologies Ltd 最近一个季度的净利润为 -3.10M。

Collplant Biotechnologies Ltd 年度营业利润是多少？



Collplant Biotechnologies Ltd 2025 财年的营业利润为 -11.35M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。